Relafen is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Advanced Rx Pharmacy Of Tennessee, Llc. The primary component is Nabumetone.
Product ID | 80425-0053_b1fdb374-8d9a-38e7-e053-2a95a90af331 |
NDC | 80425-0053 |
Product Type | Human Prescription Drug |
Proprietary Name | Relafen |
Generic Name | Nabumetone 500mg |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2019-03-06 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA078671 |
Labeler Name | Advanced Rx Pharmacy of Tennessee, LLC |
Substance Name | NABUMETONE |
Active Ingredient Strength | 500 mg/1 |
Pharm Classes | Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2019-03-06 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
73684-100 | RELAFEN | NABUMETONE |
73684-101 | RELAFEN | NABUMETONE |
80425-0052 | Relafen | Nabumetone 500mg |
80425-0053 | Relafen | Nabumetone 500mg |
80425-0054 | Relafen | Nabumetone 500mg |
80425-0104 | Relafen | Nabumetone 750mg |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
RELAFEN 87702292 not registered Live/Pending |
Argent Development Group, LLC 2017-11-29 |
RELAFEN 86251872 not registered Dead/Abandoned |
Argent Development Group, LLC 2014-04-14 |
RELAFEN 73353073 1248125 Dead/Cancelled |
Beecham Inc. 1982-03-04 |